Clinical Trials Browser

Recruiting × Endometrial Neoplasms × mirvetuximab soravtansine × Clear all

NCT03832361 2025-07-18

Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer

Phase 2 Recruiting

Endometrial Neoplasms